A recent Memorial Sloan-Kettering study shows that some circulating tumor cells can circle back and infiltrate their tumor of origin, enhancing its growth and aggressiveness.
Since joining Memorial Sloan-Kettering in 2001, medical oncologist Ghassan Abou-Alfa has specialized in treating patients who have primary liver cancer. He also investigates and tests new targeted therapies in clinical studies and advocates for greater awareness of the disease's global impact.
A recent study led by Memorial Sloan-Kettering surgeons Richard J. Wong, Yuman Fong, and Jatin P. Shah has uncovered a mechanism that allows tumor cells to sense the presence of a nerve and migrate along it.
More than 300 members of the public gathered in Memorial Sloan-Kettering's Rockefeller Research Laboratories Auditorium on March 18 to hear medical oncologist Clifford A. Hudis speak on "New Concepts, New Targets, New Directions, New Hope" in treating breast cancer.
A collaborative team of researchers from Memorial Sloan-Kettering has determined the mechanism for a biological process that plays a key role in regulating cellular behavior.
Memorial Sloan-Kettering has created a new multidisciplinary research center that promises to shed light on the role that microbes and the body's inflammatory and immunological responses to them play in the development of cancer.
Memorial Sloan-Kettering has established a fertility preservation program within the Center's Cancer Survivorship Initiative to provide information and resources to clinicians to help them initiate discussions with patients about fertility preservation.
Memorial Sloan-Kettering leadership announced in February that the Center has purchased the property formerly known as Cabrini Medical Center, located on East 19th Street in Manhattan.
Charles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program, was elected to the National Academy of Sciences at the group's 147th annual meeting in April.
Murray F. Brennan, a distinguished cancer surgeon and former Chair of Memorial Sloan-Kettering's Department of Surgery, has been named Vice President for International Programs and Director of the Elmer and Mamdouha El-Sayed Bobst International Center at Memorial Sloan-Kettering.
Doracy P. Fontenla is a board-certified medical physicist and educator whose focus has been the training of residents and fellows in radiation therapy and medical physics.
Christopher E. Comstock comes to Memorial Sloan-Kettering from the University of California, San Diego, where he served for six years as chief of the breast imaging section.